In a CRC-bearing mouse model, mice treated with adenoviral B7-H3 showed suppressed tumor growth and reduced the occurrence of secondary metastasis, with significantly higher frequencies of IFN-γ-producing CD8+ T cells and higher IL-12 levels than those in the control group (29, 30). This evidence concerns the gene CD8A and neoplasm.